Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Sreekumar Subramanian

Thoracic Surgery (Cardiothoracic Vascular Surgery) Nashville, TN Medical Doctor

NPI 1801888680 CMS profile 81277

2400 Patterson St, Suite 307, Nashville, TN 37203

Open in the dashboard

General payments

$98,459

393 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$384,379 paid to institutions, not to them · program years 2019–2025

Through program year 2025, Sreekumar Subramanian of Nashville, TN is reported in the CMS Open Payments database as having received $98,459 across 393 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $384,379 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 93rd percentile of Thoracic Surgery (Cardiothoracic Vascular Surgery) profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $7,028 47
2024 General $10,661 62
2023 General $15,293 38
2022 General $4,322 48
2021 General $10,302 40
2020 General $27,239 51
2019 General $23,613 107

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Sreekumar Subramanian
  • Thoracic Surgery (Cardiothoracic Vascular Surgery) median
  • Middle half of Thoracic Surgery (Cardiothoracic Vascular Surgery)
  • National median

In program year 2025, general payments to Sreekumar Subramanian were reported at $7,028. Among 4,073 Thoracic Surgery (Cardiothoracic Vascular Surgery) profiles paid that year, the median was $791 and the middle half received between $208 and $3,074.

Show as a table
Year Sreekumar Subramanian Thoracic Surgery (Cardiothoracic Vascular Surgery) median Middle half National median
2019 $23,613 $886 $178–$3,167 $163
2020 $27,239 $341 $108–$1,605 $114
2021 $10,302 $453 $125–$1,886 $132
2022 $4,322 $695 $180–$2,566 $149
2023 $15,293 $745 $205–$2,662 $160
2024 $10,661 $799 $214–$2,967 $164
2025 $7,028 $791 $208–$3,074 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. LivaNova USA, Inc. $50,736 54 payments
  2. Abiomed $16,715 18 payments
  3. Intuitive Surgical, Inc. $7,199 40 payments
  4. Corcym Inc $6,630 10 payments
  5. Edwards Lifesciences Corporation $4,702 31 payments
  6. Abbott Laboratories $3,502 20 payments
  7. CryoLife, Inc. $2,436 61 payments
  8. JACE Medical LLC $1,488 2 payments
  9. Atricure, Inc. $721 30 payments
  10. Boston Scientific Corporation $599 7 payments
  11. Other $3,732 120 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $48,150 15 payments
  2. Travel and Lodging $15,818 61 payments
  3. Honoraria $12,050 3 payments
  4. Food and Beverage $11,053 307 payments
  5. Consulting Fee $9,888 6 payments
  6. Education $1,500 1 payment
Products named General payments · program years 2019–2025
  1. Perceval $32,194 40 payments
  2. Memo4D Cardiology/Vascular Diseases $18,077 13 payments
  3. Impella $12,648 14 payments
  4. Memo4D Cardiology/Vascular Diseases $8,443 4 payments
  5. MEMO 4D $6,400 3 payments
  6. Da Vinci Surgical System $5,699 39 payments
  7. DAVINCI XI $1,500 1 payment
  8. MITRIS RESILIA Mitral Valve $1,407 12 payments
  9. ON-X AORTIC HEART VALVE WITH CONFORM-X SEWING RING AND EXTENDED HOLDER $1,117 31 payments
  10. BioGlue $1,077 9 payments
  11. Other $10,161 303 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 1 drug

Part D claims

11

Median for Cardiac Surgery: 68

Drug cost

$13

Median for Cardiac Surgery: $445

Branded share of claims

0%

Median for Cardiac Surgery: 15.7%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Metoprolol Tartrate Generic 11 $13

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 411 Part D prescribers listed as Cardiac Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 51 billing codes

Paid by Medicare

$116,634

Medicare's payments for the services billed

Medicare patients

95

Average age 74

Services billed

265

47 women, 48 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Ischemic heart disease 75%
Heart failure 63%
Atrial fibrillation 53%
Diabetes 47%
Arthritis 44%
Chronic kidney disease 38%
COPD 31%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

3 products · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
ELIQUIS
  • PFIZER INC. $6
$6 — —
NURTEC ODT
  • PFIZER INC. $6
$6 — —
PAXLOVID
  • PFIZER INC. $6
$6 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

Records

393 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Thoracic Surgery (Cardiothoracic Vascular Surgery) in Tennessee

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record